These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 197314)

  • 1. Total intravenous hyperalimentation and hydroxyurea chemotherapy in hepatoma-bearing rats.
    Cameron IL; Rogers W
    J Surg Res; 1977 Oct; 23(4):279-88. PubMed ID: 197314
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of growth of a transplantable hepatoma in rats by parenteral nutrition.
    Cameron IL; Pavlat WA
    J Natl Cancer Inst; 1976 Mar; 56(3):597-602. PubMed ID: 176398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of hepatoma-bearing rats to total parenteral hyperalimentation and to ad libitum feeding.
    Cameron IL; Ackley WJ; Rogers W
    J Surg Res; 1977 Sep; 23(3):189-95. PubMed ID: 196138
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of Morris hepatoma 3924A: correlation of size and weight of tumor and preliminary data with 5-fluoro-2'-deoxyuridine (5-FUDR; NSC-27640).
    Lo KW; Miller EE; Morris HP; Tsou KC
    Cancer Chemother Rep; 1973; 57(3):245-9. PubMed ID: 4356394
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antineoplastic effect of hydrogel prospidin on Seidel ascites hepatoma used as a model].
    Bychkovskiĭ PM; Iurkshtovich TL; Kladiev AA; Revtovich MIu
    Tsitologiia; 2012; 54(3):230-5. PubMed ID: 22645987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.
    Rizzi PM; Ryder SD; Ramage JK; Gane E; Karani J; Heaton N; Portmann B; Tan KC; Williams R
    Transplant Proc; 1994 Dec; 26(6):3568-9. PubMed ID: 7527979
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential sensitivities of five rat hepatoma cell lines to anticancer drugs.
    Barranco SC; Haenelt BR; Gee EL
    Cancer Res; 1978 Mar; 38(3):656-60. PubMed ID: 75057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of doxifluridine in the treatment of primary hepatocellular carcinoma.
    Lai KH; Tsai YT; Lee SD; Yeh YS; Wang SS; Ng WW; Wang JY; Chiang TT; Lay CS; Yang CF
    Cancer Treat Rep; 1986 Nov; 70(11):1339-40. PubMed ID: 3021327
    [No Abstract]   [Full Text] [Related]  

  • 9. Sorafenib plus cisplatin for hepatocellular carcinoma.
    Brower V
    Lancet Oncol; 2016 Oct; 17(10):e424. PubMed ID: 27617663
    [No Abstract]   [Full Text] [Related]  

  • 10. How to overcome multidrug resistance in chemotherapy for advanced hepatocellular carcinoma.
    Ryu SH; Chung YH
    Liver Int; 2010 Apr; 30(4):496-8. PubMed ID: 20456038
    [No Abstract]   [Full Text] [Related]  

  • 11. Regorafenib: a newly approved drug for advanced hepatocellular carcinoma.
    Kyrochristos ID; Ziogas DE; Roukos DH
    Future Oncol; 2017 Aug; 13(19):1665-1668. PubMed ID: 28613123
    [No Abstract]   [Full Text] [Related]  

  • 12. Immuno-modulatory and cellular antioxidant activities of κ-selenocarrageenan in combination with Epirubicin in H22 hepatoma-bearing mice.
    Ling N; Zhou X; Ji Y; Li W; Ji C; Qi Z
    Biomed Pharmacother; 2017 Jul; 91():132-137. PubMed ID: 28448867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC).
    Mueller PR
    Jpn J Cancer Res; 1995 Nov; 86(11):inside front cover. PubMed ID: 8567388
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial inhibition of hydroxyurea on liver tumors induced by N, N-dimethyl-4-aminoazobenzene.
    Lin JK; Chiu IS
    Taiwan Yi Xue Hui Za Zhi; 1974 Apr; 73(4):220-6. PubMed ID: 4368991
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the long-term efficacy of percutaneous ethanol injection for small hepatocellular carcinoma?
    Sherman M
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):78-9. PubMed ID: 16456573
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma.
    Woo HY; Bae SH; Park JY; Han KH; Chun HJ; Choi BG; Im HU; Choi JY; Yoon SK; Cheong JY; Cho SW; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH;
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):373-82. PubMed ID: 19763572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatoma activity and mechanism of corn silk polysaccharides in H22 tumor-bearing mice.
    Yang J; Li X; Xue Y; Wang N; Liu W
    Int J Biol Macromol; 2014 Mar; 64():276-80. PubMed ID: 24315949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hepatoma.
    van Dyk JJ
    Proc Mine Med Off Assoc SA; 1975; 55(421):19-20. PubMed ID: 209446
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased urinary excretion of cyclic guanosine monophosphate in rats bearing Morris hepatoma 3924A.
    Murad F; Kimura H; Hopkins HA; Looney WB; Kovacs CJ
    Science; 1975 Oct; 190(4209):58-60. PubMed ID: 170677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial infusion chemotherapy of hepatoma.
    Cady B; Oberfield RA
    Surg Gynecol Obstet; 1974 Mar; 138(3):381-4. PubMed ID: 4359590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.